Abstract
Vibrio vulnificus (V. vulnificus) is a useful model for bacterial septicemia as the bacterial infection generates a wide pathogenic spectrum in addition to a high mortality rate. This study was aimed at investigating the effects of genistein on the growth, cytotoxicity, adhesion, and the mouse mortality caused by V. vulnificus. The results of our study indicated that genistein (50 or 100 mg/L) effectively minimized the morphologic damages and inhibited acute death of HeLa cells by V. vulnificus. Strikingly, genistein significantly inhibited the adhesion of V. vulnificus to HeLa cells. This report confirmed that genistein showed bacteriostatic activity against V. vulnificus, but it did not exhibit any bactericidal activity. Nevertheless, genistein (20 mg/kg) effectively decreased CD-1 mice mortality caused by V. vulnificus infection.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Akiyama, T., Ishida, J., Nakagawa, S., Ogawara, H., Watanabe, S., Itoh, N., Shibuya, M., and Fukami, Y., Genistein, a specific inhibitor of tyrosine-specific protein kinases. J. Biol. Chem., 262, 5592–5595 (1987).
Fred Wong, W. S., Koh, Diana S. K., Koh, Alan H. M., Ting, W. L., and Wong, Peter T. H., Effects of Tyrosine Kinase Inhibitors on Antigen Challenge of Guinea Pig Lung In Vitro. JPET, 283, 131–137 (1997).
Gadgeel, S. M., Ali, S., Philip, P. A., Wozniak, A., and Sarkar, F. H., Genistein enhances the effect of epidermal growth factor receptor tyrosine kinase inhibitors and inhibits nuclear factor kappa B in nonsmall cell lung cancer cell lines. Cancer, 115, 2165–2176 (2009).
Gray, L. D. and Kreger, A. S., Detection of anti-Vibrio vulnificus cytolysin antibodies in sera from mice and a human surviving V. vulnificus disease. Infect. Immun., 51, 964–965 (1986).
Hong, H., Landauer, M. R., Foriska, M. A., and Ledney, G. D., Antibacterial activity of the soy isoflavone Genistein. J. Basic Microbiol., 46, 329–335 (2006).
Hwang, J. T., Lee, Y. K., Shin, J. I., and Park, O. J., Antiinflammatory and anti-carcinogenic effect of Genistein alone or in combination with capsaicin in TPA-treated rat mammary glands or mammary cancer cell line. Ann. N. Y. Acad. Sci., 1171, 415–420 (2009).
Kim, Y. R., Lee, S. E., Kim, C. M., Kim, S. Y., Shin, E. K., Shin, D. H., Chung, S. S., Choy, H. E., Progulske-Fox, A., Hillman, J. D., Handfield, M., and Rhee, J. H., Characterization and pathogenic significance of Vibrio vulnificus antigens preferentially expressed in septicemic patients. Infect. Immun., 71, 5461–5471 (2003).
Kim, Y. R. and Rhee, J. H., Flagellar basal body flg operon as a virulence determinant of Vibrio vulnificus. Biochem. Biophys. Res. Commun., 304, 405–410 (2003).
Kim, Y. R., Lee, S. E., Kook, H., Yeom, J. A., Na, H. S., Kim, S. Y., Chung, S. S., Choy, H. E., and Rhee, J. H., Vibrio vulnificus RTX toxin kills host cells only after contact of the bacteria with host cells. Cell. Microbiol., 10, 848–862 (2008).
Kothary, M. H. and Kreger, A. S., Purification and characterization of an elastolytic protease of Vibrio vulnificus. J. Gen. Microbiol., 133, 1783–1791 (1987).
Kreger, A. and Lockwood, D., Detection of extracellular toxin(s) produced by Vibrio vulnificus. Infect. Immun., 33, 583–590 (1981).
Lee, J. H., Kim, M. W., Kim, B. S., Kim, S. M., Lee, B. C., Kim, T. S., and Choi, S. H., Identification and characterization of the Vibrio vulnificus rtxA essential for cytotoxicity in vitro and virulence in mice. J. Microbiol., 45, 146–152 (2007).
Liggins, J., Bluck, L. J., Runswick, S., Atkinson, C., Coward, W. A., and Bingham, S. A., Daidzein and Genistein contents of vegetables. Br. J. Nut., 84, 717–725 (2000).
Oliver, J. D., Wound infections caused by Vibrio vulnificus and other marine bacteria. Epidemiol. Infect., 133, 383–391 (2005).
Polkowski, K., Popiolkiewicz, J., Krzeczynski, P., Ramza, J., Pucko, W., Zegrocka-stendel, O., Boryski, J., Skierski, J. S., and Mazurek, A. P., Grynkiewicz G. Cytostatic and cytotoxic activity of synthetic Genistein glycosides against human cancer cell lines. Cancer Lett., 203, 59–69 (2004).
Reddy, G. P., Hayat, U., Abeygunawardana, C., Fox, C., Wright, A. C., Maneval, D. R., Jr., Bush, C. A., and Morris, J. G., Jr., Purification and determination of the structure of capsular polysaccharide of Vibrio vulnificus M06-24. J. Bacteriol., 174, 2620–2630 (1992).
Roy, K., Hilliard, G. M., Hamilton, D. J., Luo, J., Ostmann, M. M., and Fleckenstein, J. M., Enterotoxigenic Escherichia coli EtpA mediates adhesion between flagella and host cells. Nature, 457, 594–598 (2009).
Sarkar, F. H. and Li, Y., The role of isoflavones in cancer chemoprevention. Front. Biosci., 9, 2714–2724 (2004).
Simpson, L. M. and Oliver, J. D., Siderophore production by Vibrio vulnificus. Infect. Immun., 41, 644–649 (1983).
Tacket, C. O., Brenner, F., and Blake, P. A., Clinical features and an epidemiological study of Vibrio vulnificus infections. J. Infect. Dis., 149, 558–561 (1984).
Testa, J., Daniel, L. W., and Kreger, A. S., Extracellular phospholipase A2 and lysophospholipase produced by Vibrio vulnificus. Infect. Immun., 45, 458–463 (1984).
Verdrengh, M., Collins, L. V., Bergin, P., and Tarkowski, A., Phytoestrogen Genistein as an anti-staphylococcal agent. Microbes Infect., 6, 86–92 (2004).
Verdrengh, M., Jonsson, I. M., Holmdahl, R., and Tarkowski, A., Genistein as an anti-inflammatory agent. Inflamm. Res., 52, 341–346 (2003).
Wei, H., Bowen, R., Cai, Q., Barnes, S., and Wang, Y., Antioxidant and antipromotional effects of the soybean isoflavone Genistein. Proc. Soc. Exp. Biol. Med., 208, 124–130 (1995).
Wright, A. C., Simpson, L. M., Oliver, J. D., and Morris, Jr. J. G., Phenotypic evaluation of acapsular transposon mutants of Vibrio vulnificus. Infect. Immun., 58, 1769–1773 (1990).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Oh, DR., Kim, J.R. & Kim, Y.R. Genistein inhibits Vibrio vulnificus adhesion and cytotoxicity to HeLa cells. Arch. Pharm. Res. 33, 787–792 (2010). https://doi.org/10.1007/s12272-010-0520-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12272-010-0520-y